← Open Payments lookup

EDWIN CABAHUG: Open Payments

NPI 1972055952 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,041 in 20 payments from 11 companies in 2025. Trend: 2023 $225 · 2024 $481 · 2025 $1,041

Food & beverage: $1,041
CompanyPaymentsAmount
Amgen Inc.4$151
GlaxoSmithKline, LLC.4$149
Gilead Sciences, Inc.1$140
Lilly USA, LLC3$132
Novo Nordisk Inc1$125
Abbott Laboratories1$113
E.R. Squibb & Sons, L.L.C.1$110
VERTEX PHARMACEUTICALS INCORPORATED2$42
Dexcom, Inc.1$34
Merck Sharp & Dohme LLC1$28

Products named: Epclusa, Ozempic, FREESTYLE LIBRE 3, Repatha, AREXVY, CAMZYOS, ZEPBOUND, JOURNAVX.

Industry payments across CA — which companies pay providers there.